A phase II randomized controlled trial of atorvastatin therapy in intensive care patients with severe sepsis

  • Kruger, Peter (Primary Chief Investigator (PCI))
  • Venkatesh, Balasubramanian (Chief Investigator (CI))
  • Bellomo, Rinaldo (Chief Investigator (CI))
  • Kostner, Karam (Chief Investigator (CI))
  • Cooper, Jamie (Chief Investigator (CI))
  • Roberts, Michael (Chief Investigator (CI))

Project: Research

Project Details

Effective start/end date2/01/0730/06/11


  • National Health and Medical Research Council (NHMRC) (Australia): A$603,825.00